AMWL
$5.60
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scala...
Recent News
HIMS Expands Personalized Digital Healthcare Access and Services
Hims & Hers expands its digital care platform with labs tracking, multi-cancer screening access and broader treatments as it scales personalized healthcare globally.
Stock Market Today, March 12: Hims and Hers Health Drops After Rally Sparks Profit Taking
On March 12, 2026, investors weighed profit-taking against a high-stakes pivot toward branded obesity drugs and telehealth growth.
Stock Market Today, March 9: Hims & Hers Health Soars on Novo Nordisk Weight-Loss Drug Deal
On March 9, 2026, a new Novo Nordisk pact reshaped this telehealth player’s GLP-1 strategy, margins, and legal risk profile.
American Well (AMWL) Is Attractively Priced Despite Fast-paced Momentum
American Well (AMWL) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Is American Well (AMWL) Stock Outpacing Its Medical Peers This Year?
Here is how American Well Corporation (AMWL) and Catalyst Pharmaceutical (CPRX) have performed compared to their sector so far this year.